RenovoRx Expands Scientific Advisory Board with Appointment of Michel Ducreux, M.D., Ph.D.
RenovoRx, Inc. , a clinical-stage biopharmaceutical company developing targeted combination therapies, today announced the appointment of Michel Ducreux, M.D., Ph.D. to the Company’s Scientific...
France General Shaun Bagai Michel Ducreux Gustave Roussy Gastrointestinal Tract Cancer Group European Organisation For Research
Source: marketscreener.com